Literature DB >> 7076794

High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel.

M J Tikkanen, E A Nikkilä, T Kuusi, S U Sipinen.   

Abstract

The concentrations of plasma high density lipoprotein (HDL) and its subfraction HDL2 are influenced by endogenous and exogenous sex hormones. The catabolism of HDL2 is mediated by a lipolytic enzyme, hepatic lipase, which is present in endothelial cells covering the liver sinusoids. Since the activity of this enzyme is also regulated by gonadal and anabolic steroids, we examined whether the effect of sex steroids on plasma HDL is related to changes in hepatic lipase. In postmenopausal women, estradiol valerate (2 mg/day, orally) increased the HDL2 cholesterol and phospholipid concentrations by 20% (P less than 0.05). Simultaneously, the hepatic lipase activity of postheparin plasma decreased by 25% (P less than 0.05). The addition of levonorgestrel (250 micrograms/day, orally) to the treatment reversed both effects of estrogen, so that HDL2 cholesterol and phospholipid levels fell below and hepatic lipase activity rose above the respective pretreatment values. The hormones did not influence the HDL3 lipid concentrations or the lipoprotein lipase and lecithin:cholesterol acyltransferase activities. The results are compatible with the hypothesis that the effects of sex steroids on plasma HDL (HDL2) are mediated by changes in hepatic lipase activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076794     DOI: 10.1210/jcem-54-6-1113

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  R H Foster; J A Balfour
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.

Authors:  Anuja Dokras; Martin Playford; Penny M Kris-Etherton; Allen R Kunselman; Christy M Stetter; Nancy I Williams; Carol L Gnatuk; Stephanie J Estes; David B Sarwer; Kelly C Allison; Christos Coutifaris; Nehal Mehta; Richard S Legro
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-09       Impact factor: 3.478

Review 3.  Sex steroids and the cardiovascular system.

Authors:  C Christiansen
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.

Authors:  P V Luoma; J E Heikkinen; C Ehnholm; P R Ylöstalo
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

6.  [Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease].

Authors:  J M Chemnitius; H Winkel; I Meyer; K Schirrmacher; V W Armstrong; H Kreuzer; R Zech
Journal:  Med Klin (Munich)       Date:  1998-03-15

Review 7.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

8.  Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone.

Authors:  S P Tam; T K Archer; R G Deeley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Variations in high-density lipoprotein subclasses during the menstrual cycle.

Authors:  P T Williams; M A Austin; R M Krauss
Journal:  Metabolism       Date:  1994-11       Impact factor: 8.694

10.  Compositional changes and apoprotein A-I metabolism of plasma high density lipoprotein in estrogenized chicks.

Authors:  B H Cho; J R Park
Journal:  Lipids       Date:  1991-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.